Data protection Impressum

Financing

Since 2016, the MassChallenge program has been a cornerstone in accelerating over 720 start-ups, aiding them in raising more than CHF 1.2 billion in funding and generating over 50,000 jobs.

Perovskia Solar and Impossible Materials triumph at the MassChallenge Switzerland Awards 2023

31 October 2023

Thomas Ingold, CEO and Founder of DroneControl Sàrl.

Four innovative Geneva start-ups receive FIF support

31 October 2023

Western Switzerland's commitment to 3D printing and manufacturing is multi-faceted, bridging research, industry, and academia.

3D printing and manufacturing in Western Switzerland

25 October 2023

Pyrpose blends decentralized and regenerative finance to create a platform where consumers and businesses collaborate to reduce climate emissions.

Pyrpose’s finance platform bridges gap between consumers and climate innovators

24 October 2023

The increasing global demand for low-carbon solutions underscores the pivotal role Nanogence's smart catalyst technology is set to play in the building and construction realm.

Nanogence secures funding to propel low-carbon tech in construction

23 October 2023

Solarsplit aims to make solar energy more accessible by streamlining and enhancing the profitability of the photovoltaic panel installation process.

Solarsplit wins the top spot at the Prix BCV Innovation 2023 awards

23 October 2023

From left to right: Prof. Han (Professor of Yonsei Cancer Center), Dr. Chun (CSO of Oncosoft), Prof. Dong Wook Kim (Clinical Professor, Yonsei Cancer Center), Laura Acosta (Swiss Embassy Representative), Prof. Ik Jae Lee (Director of Heavy Ion Therapy, Yonsei Cancer Center), Dr. Christina Vallgren (CEO of Terapet), Herve Duffour (Sales and Marketing director of Terapet), Prof. Jin Sung Kim (Chief Medical Physicist of Yonsei Cancer Center & CEO of Oncosoft).

Terapet enters partnership with Korean entities for its breakthrough cancer therapy device

18 October 2023

Mimix’s objective, as outlined in its strategic vision, is to introduce this wound care product to the US market by the second half of 2024.

Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment

17 October 2023

From left to right: Nicolas Weber, CEO of Voltiris, Nasri Nahas, CEO of Biopôle SA, Jonas Roch, CTO of Voltiris and Pierre-Jean Wipff, Innovation and Partnerships Director at Biopôle.

Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund

11 October 2023

Sparta Commodities’ solution represents a paradigm of future-oriented, real-time market insights that elevates commodity trading to novel heights.

USD 17.5 million to expand Sparta’s intelligent commodity trading solution globally

11 October 2023

1 … 14 15 16 17 18 19 20 21 22 … 33